How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation survey.

Autor: Prior JA; School of Medicine, Keele University, Keele, UK.; Rheumatology Department, Midlands Partnership University NHS Foundation Trust, Newcastle-Under-Lyme, UK., Roddy E; School of Medicine, Keele University, Keele, UK.; Rheumatology Department, Midlands Partnership University NHS Foundation Trust, Newcastle-Under-Lyme, UK., Solis-Trapala I; School of Medicine, Keele University, Keele, UK., Cornwall N; School of Medicine, Keele University, Keele, UK., Jinks C; School of Medicine, Keele University, Keele, UK., Abhishek A; Academic Rheumatology, School of Medicine, University of Nottingham, Nottingham, UK., Bukhari M; Rheumatology Department, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK., Galloway J; Centre for Rheumatic Diseases, Kings College London, London, UK., Goodson N; Rheumatology Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Jowett S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Hider S; School of Medicine, Keele University, Keele, UK.; Rheumatology Department, Midlands Partnership University NHS Foundation Trust, Newcastle-Under-Lyme, UK.
Jazyk: angličtina
Zdroj: Rheumatology advances in practice [Rheumatol Adv Pract] 2023 Nov 15; Vol. 7 (3), pp. rkad102. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).
DOI: 10.1093/rap/rkad102
Databáze: MEDLINE